Free Trial

STRATA Skin Sciences (SSKN) Competitors

STRATA Skin Sciences logo
$2.83 -0.03 (-1.05%)
As of 01:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SSKN vs. NXL, MBOT, BLAC, OM, CLGN, MDAI, BDMD, NMTC, DXR, and XAIR

Should you be buying STRATA Skin Sciences stock or one of its competitors? The main competitors of STRATA Skin Sciences include Nexalin Technology (NXL), Microbot Medical (MBOT), Bellevue Life Sciences Acquisition (BLAC), Outset Medical (OM), CollPlant Biotechnologies (CLGN), Spectral AI (MDAI), Baird Medical Investment (BDMD), NeuroOne Medical Technologies (NMTC), Daxor (DXR), and Beyond Air (XAIR). These companies are all part of the "medical equipment" industry.

STRATA Skin Sciences vs.

Nexalin Technology (NASDAQ:NXL) and STRATA Skin Sciences (NASDAQ:SSKN) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, community ranking, valuation, dividends, analyst recommendations, media sentiment, earnings and profitability.

Nexalin Technology has higher earnings, but lower revenue than STRATA Skin Sciences. Nexalin Technology is trading at a lower price-to-earnings ratio than STRATA Skin Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nexalin Technology$110K351.24-$4.65M-$0.64-4.54
STRATA Skin Sciences$33.36M0.35-$10.83M-$2.66-1.06

STRATA Skin Sciences has a net margin of -28.72% compared to Nexalin Technology's net margin of -3,407.98%. STRATA Skin Sciences' return on equity of -69.33% beat Nexalin Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
Nexalin Technology-3,407.98% -187.59% -167.21%
STRATA Skin Sciences -28.72%-69.33%-17.55%

Nexalin Technology has a beta of 4.2, indicating that its share price is 320% more volatile than the S&P 500. Comparatively, STRATA Skin Sciences has a beta of 1.33, indicating that its share price is 33% more volatile than the S&P 500.

STRATA Skin Sciences received 222 more outperform votes than Nexalin Technology when rated by MarketBeat users. Likewise, 63.90% of users gave STRATA Skin Sciences an outperform vote while only 50.00% of users gave Nexalin Technology an outperform vote.

CompanyUnderperformOutperform
Nexalin TechnologyOutperform Votes
1
50.00%
Underperform Votes
1
50.00%
STRATA Skin SciencesOutperform Votes
223
63.90%
Underperform Votes
126
36.10%

In the previous week, Nexalin Technology had 2 more articles in the media than STRATA Skin Sciences. MarketBeat recorded 2 mentions for Nexalin Technology and 0 mentions for STRATA Skin Sciences. Nexalin Technology's average media sentiment score of 1.11 beat STRATA Skin Sciences' score of 0.00 indicating that Nexalin Technology is being referred to more favorably in the media.

Company Overall Sentiment
Nexalin Technology Positive
STRATA Skin Sciences Neutral

Nexalin Technology currently has a consensus price target of $3.00, suggesting a potential upside of 3.27%. Given Nexalin Technology's stronger consensus rating and higher possible upside, research analysts plainly believe Nexalin Technology is more favorable than STRATA Skin Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nexalin Technology
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
STRATA Skin Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

0.7% of Nexalin Technology shares are owned by institutional investors. Comparatively, 32.4% of STRATA Skin Sciences shares are owned by institutional investors. 24.0% of Nexalin Technology shares are owned by company insiders. Comparatively, 39.0% of STRATA Skin Sciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

STRATA Skin Sciences beats Nexalin Technology on 9 of the 17 factors compared between the two stocks.

Get STRATA Skin Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for SSKN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SSKN vs. The Competition

MetricSTRATA Skin SciencesSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$11.80M$4.60B$5.81B$9.02B
Dividend YieldN/A39.91%4.78%3.85%
P/E Ratio-1.0630.2326.2318.96
Price / Sales0.3550.18453.4377.29
Price / CashN/A51.2344.0437.47
Price / Book0.786.597.664.69
Net Income-$10.83M$90.13M$3.18B$245.69M
7 Day Performance1.29%-1.73%-1.36%-1.85%
1 Month Performance-1.74%-1.66%0.73%-1.54%
1 Year Performance-43.41%15.71%17.60%14.60%

STRATA Skin Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SSKN
STRATA Skin Sciences
1.1978 of 5 stars
$2.83
-1.0%
N/A-46.6%$11.80M$33.36M-1.06120Gap Down
NXL
Nexalin Technology
1.2338 of 5 stars
$3.52
-5.4%
$3.00
-14.8%
+881.8%$46.82M$110,000.00-5.503
MBOT
Microbot Medical
1.8476 of 5 stars
$2.31
-9.4%
$9.00
+289.6%
+35.3%$46.75MN/A-2.8920High Trading Volume
BLAC
Bellevue Life Sciences Acquisition
N/A$10.93
-2.6%
N/A-70.6%$44.15MN/A0.00N/AGap Down
OM
Outset Medical
1.7397 of 5 stars
$0.79
-3.1%
$4.50
+473.2%
-71.3%$42.15M$130.38M-0.28520Earnings Report
News Coverage
CLGN
CollPlant Biotechnologies
2.21 of 5 stars
$3.63
-1.0%
$12.50
+244.8%
-36.9%$41.51M$10.96M-2.3570High Trading Volume
MDAI
Spectral AI
2.6091 of 5 stars
$2.22
+7.8%
$4.75
+114.0%
+7.0%$41.27M$18.06M-3.4283Gap Up
BDMD
Baird Medical Investment
N/A$6.23
+5.6%
N/AN/A$40.99MN/A0.00N/A
NMTC
NeuroOne Medical Technologies
0.1229 of 5 stars
$1.20
+12.1%
N/A+1.8%$37.03M$3.45M-2.6120
DXR
Daxor
3.4586 of 5 stars
$7.19
-3.6%
$24.75
+244.2%
-18.7%$34.80MN/A0.0037
XAIR
Beyond Air
4.5546 of 5 stars
$0.44
+5.4%
$3.67
+737.7%
-82.1%$33.28M$1.16M-0.3170High Trading Volume

Related Companies and Tools


This page (NASDAQ:SSKN) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners